Free Trial
→ Please open before June 12! (From InvestPub) (Ad)tc pixel Free NVOS Stock Alerts

Novo Integrated Sciences (NVOS) Competitors

$0.0090 0.00 (0.00%)
As of 06/10/2026
Compare

NVOS vs. LBGJ, HLP, STRCW, ASML, and JCI

Should you buy Novo Integrated Sciences stock or one of its competitors? MarketBeat compares Novo Integrated Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Novo Integrated Sciences include Li Bang International (LBGJ), Hongli Group (HLP), Palladyne AI (STRCW), ASML (ASML), and Johnson Controls International (JCI). These companies are all part of the "machinery" industry.

How does Novo Integrated Sciences compare to Li Bang International?

Novo Integrated Sciences (NASDAQ:NVOS) and Li Bang International (NASDAQ:LBGJ) are both small-cap machinery companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Li Bang International has lower revenue, but higher earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.01-$16.17M-$0.87N/A
Li Bang International$12.67M0.11-$1.01MN/AN/A

Novo Integrated Sciences has a beta of 5.94, indicating that its share price is 494% more volatile than the broader market. Comparatively, Li Bang International has a beta of 2.94, indicating that its share price is 194% more volatile than the broader market.

Li Bang International has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. Li Bang International's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
Li Bang International N/A N/A N/A

In the previous week, Li Bang International had 3 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 3 mentions for Li Bang International and 0 mentions for Novo Integrated Sciences. Li Bang International's average media sentiment score of 1.10 beat Novo Integrated Sciences' score of 0.00 indicating that Li Bang International is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
Li Bang International Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Li Bang International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Li Bang International beats Novo Integrated Sciences on 8 of the 12 factors compared between the two stocks.

How does Novo Integrated Sciences compare to Hongli Group?

Novo Integrated Sciences (NASDAQ:NVOS) and Hongli Group (NASDAQ:HLP) are both machinery companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

Hongli Group has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.01-$16.17M-$0.87N/A
Hongli Group$19.60MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hongli Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Hongli Group has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. Hongli Group's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
Hongli Group N/A N/A N/A

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Hongli Group had 4 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 4 mentions for Hongli Group and 0 mentions for Novo Integrated Sciences. Hongli Group's average media sentiment score of 1.12 beat Novo Integrated Sciences' score of 0.00 indicating that Hongli Group is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
Hongli Group Positive

Summary

Hongli Group beats Novo Integrated Sciences on 7 of the 9 factors compared between the two stocks.

How does Novo Integrated Sciences compare to Palladyne AI?

Palladyne AI (NASDAQ:STRCW) and Novo Integrated Sciences (NASDAQ:NVOS) are both machinery companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Palladyne AI has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. Palladyne AI's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Palladyne AIN/A N/A N/A
Novo Integrated Sciences -121.55%-93.07%-46.28%

Palladyne AI has higher earnings, but lower revenue than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palladyne AIN/AN/AN/AN/AN/A
Novo Integrated Sciences$13.52M0.01-$16.17M-$0.87N/A

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Palladyne AI had 2 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 2 mentions for Palladyne AI and 0 mentions for Novo Integrated Sciences. Palladyne AI's average media sentiment score of 0.43 beat Novo Integrated Sciences' score of 0.00 indicating that Palladyne AI is being referred to more favorably in the media.

Company Overall Sentiment
Palladyne AI Neutral
Novo Integrated Sciences Neutral

Summary

Palladyne AI beats Novo Integrated Sciences on 5 of the 8 factors compared between the two stocks.

How does Novo Integrated Sciences compare to ASML?

Novo Integrated Sciences (NASDAQ:NVOS) and ASML (NASDAQ:ASML) are both machinery companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

ASML has a consensus price target of $1,589.63, indicating a potential downside of 16.31%. Given ASML's stronger consensus rating and higher probable upside, analysts plainly believe ASML is more favorable than Novo Integrated Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ASML
3 Sell rating(s)
5 Hold rating(s)
20 Buy rating(s)
4 Strong Buy rating(s)
2.78

In the previous week, ASML had 58 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 58 mentions for ASML and 0 mentions for Novo Integrated Sciences. ASML's average media sentiment score of 0.80 beat Novo Integrated Sciences' score of 0.00 indicating that ASML is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
ASML Positive

5.7% of Novo Integrated Sciences shares are owned by institutional investors. Comparatively, 26.1% of ASML shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Novo Integrated Sciences has a beta of 5.94, meaning that its stock price is 494% more volatile than the broader market. Comparatively, ASML has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market.

ASML has higher revenue and earnings than Novo Integrated Sciences. Novo Integrated Sciences is trading at a lower price-to-earnings ratio than ASML, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.01-$16.17M-$0.87N/A
ASML$36.95B20.22$10.87B$27.8868.13

ASML has a net margin of 27.65% compared to Novo Integrated Sciences' net margin of -121.55%. ASML's return on equity of 48.69% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
ASML 27.65%48.69%19.91%

Summary

ASML beats Novo Integrated Sciences on 15 of the 17 factors compared between the two stocks.

How does Novo Integrated Sciences compare to Johnson Controls International?

Novo Integrated Sciences (NASDAQ:NVOS) and Johnson Controls International (NYSE:JCI) are both machinery companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

5.7% of Novo Integrated Sciences shares are owned by institutional investors. Comparatively, 90.1% of Johnson Controls International shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Comparatively, 0.3% of Johnson Controls International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Johnson Controls International has a net margin of 14.45% compared to Novo Integrated Sciences' net margin of -121.55%. Johnson Controls International's return on equity of 19.50% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
Johnson Controls International 14.45%19.50%7.02%

Johnson Controls International has higher revenue and earnings than Novo Integrated Sciences. Novo Integrated Sciences is trading at a lower price-to-earnings ratio than Johnson Controls International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.01-$16.17M-$0.87N/A
Johnson Controls International$23.60B3.73$3.29B$5.5925.77

In the previous week, Johnson Controls International had 33 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 33 mentions for Johnson Controls International and 0 mentions for Novo Integrated Sciences. Johnson Controls International's average media sentiment score of 1.23 beat Novo Integrated Sciences' score of 0.00 indicating that Johnson Controls International is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
Johnson Controls International Positive

Johnson Controls International has a consensus price target of $152.85, indicating a potential upside of 6.09%. Given Johnson Controls International's stronger consensus rating and higher possible upside, analysts clearly believe Johnson Controls International is more favorable than Novo Integrated Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Johnson Controls International
1 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.52

Novo Integrated Sciences has a beta of 5.94, indicating that its share price is 494% more volatile than the broader market. Comparatively, Johnson Controls International has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Summary

Johnson Controls International beats Novo Integrated Sciences on 15 of the 17 factors compared between the two stocks.

Get Novo Integrated Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVOS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVOS vs. The Competition

Export
MetricNovo Integrated SciencesEngines & turbines IndustryMedical SectorNASDAQ Exchange
Market Cap$178K$442.26M$6.46B$11.73B
Dividend YieldN/A4.21%2.67%5.56%
P/E Ratio-0.015.3524.1724.35
Price / Sales0.011.24534.05122.29
Price / CashN/A3.9743.2054.62
Price / Book0.010.4210.566.82
Net Income-$16.17M$2.66M$3.56B$337.41M
7 Day PerformanceN/A5.95%0.22%2.49%
1 Month PerformanceN/A2.04%0.66%3.69%
1 Year PerformanceN/A-20.93%22.16%27.72%

Novo Integrated Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVOS
Novo Integrated Sciences
N/A$0.01
flat		N/AN/A$178K$13.52MN/A170
LBGJ
Li Bang International
1.0217 of 5 stars		$0.96
+0.3%		N/A-99.3%$1.18M$11.11MN/AN/A
HLP
Hongli Group
N/A$0.52
-6.1%		N/A-35.3%$0.00$19.60MN/A207
STRCW
Palladyne AI
N/A$0.05
+14.5%		N/A-92.1%$0.00N/AN/A70
ASML
ASML
3.5204 of 5 stars		$1,757.47
+1.8%		$1,589.63
-9.6%		+142.3%$691.18B$36.95B63.0444,209

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NVOS) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
THIS billionaire could hold your financial fate
60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab t...
Chaikin Analytics | Sponsoredtc pixel
SMX Could Turn Proof Technology into Major Profit!
SMX (Security Matters) PLC embeds invisible molecular markers into plastics, metals, fuels, and textiles, link...
Smallcaps Daily | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump is positioned. Elon lights the fuse.
A few days ago, while the market was bleeding, Trump posted on Truth Social, "The New Frontier of Finance is b...
Crypto 101 Media | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
VWAV: Is This the Next Defense Breakout?
VisionWave Holdings, Inc. (NASDAQ: VWAV) is developing a full-stack defense technology platform that integrate...
Equiscreen | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel